Clinical Study of the Hyperviscosity Syndrome in Waldenström Macroglobulinemia

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 14, 2021

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2026

Conditions
Hyperviscosity SyndromeWaldenstrom Macroglobulinemia
Interventions
OTHER

fundoscopic picture

A central review of numerised fundoscopic picture will be performed.

BIOLOGICAL

blood sample

"Two 10 ml blood vials will be sampled in addition to standard blood sampling for getting 6 to 7 200 μL aliquot.~One 5 ml EDTA vial for GP1bα expression study, only if this sample can be sent to hemostasis laboratory within the 4 hours after sampling"

PROCEDURE

bone marrow sample

Five to 10 ml bone marrow sample will be collected in addition to standard bone marrow sampling for getting molecular characteristics of WM

Trial Locations (1)

80480

RECRUITING

CHU Amiens, Amiens

All Listed Sponsors
collaborator

Centre Hospitalier Saint Vincent

UNKNOWN

collaborator

Centre Henri Becquerel

OTHER

collaborator

University Hospital, Caen

OTHER

collaborator

University Hospital, Lille

OTHER

collaborator

Centre Hospitalier de Lens

OTHER

lead

Centre Hospitalier Universitaire, Amiens

OTHER